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 Prevalence: ranging  from 0.14% in the japanese  
to 0.61% in europeans & may reach to 3%  in 
southeast Asia. 
 In up to 60%  of patients ,the disease can be 
sporadic . 
 A FH of unexplained SCD is present in 
approximately 20% to 40% of BS. 
 The age of onset of clinical manifestation 
(syncope or  cardiac arrest) is the third to fourth 
decade of life(mean age of occurrence ,41+_ 15 
years. 
 The patient is high risk of rapid polymorphic VT 
,VF and SCD: 
 Agonal respirations,nocturnal labored respiration 
with agitation,and seizures are the only 
symptoms the patient may have before SCD  
occurs. 
 Some episodes of syncope or SCD can be triggered 
by fever,large meals (gastric distention),alcohol and 
cocain toxicity, and drugs. 
 In fact,it now appears that many previously 
described episodes of “febril seizures” may in fact 
represent bouts of polymorphic VT in patients with 
temperature-sensitive mutations. 
 AF is observed in 10% to 20% of patients. 
 The identification of concomitant conduction 
defects(PR interval>210 ms,and HV interval >60 
ms) has been shown to correlate with the 
presence of SCN5A mutations.Therefore,all 
SCN5A-positive patients should be closely 
monitored for the onset of conduction block. 
 Type 1:ST elevation  of at least 2mm with a coved 
morphology,incomplete or complete RBBB pattern  
and followed by a descending negative T wave,with 
little or no isoelectric separation . 
 Type2:saddleback  appearance with a high take-off 
ST segment elevation of at least 2 mm, positive or 
biphasic T wave. 
 Type3:has either a saddleback or coved appearance 
with an ST segment elevation of less than 1 mm.  
 Type 1 :diagnostic of BS 
 Type 2 & 3:suggestive but not specific 
 
 Cephalad placement of the right precordial leads 
(up to 2th intercostal space above normal)can 
increase the sensitivity for detecting the BS 
 A slight prolongation of the QT interval is 
sometimes observed in association with ST 
segment elevation in patients with the BS. 
 The QT is proloned more in the right precordial  
leads than it is in the left precordial 
leads,presumably  because of a preferential 
prolongation of action potential duration in right  
ventricular epicardium secondary to 
accentuation of the action potential notch.  
 SAECG:late potentials in 60% to 70% of 
clinically affected BS . 
 ETT:can potentially aggrevate the ECG 
abnormalities in the BS,including 
widening of the QRS,prolongation of the 
QTc duration 
 Criteria: 
 Type 1 ST elevation in more than one right 
precordial lead ,in conjunction with one of 
following : 
 1.documanted VF  ;2.polymorphic VT; 
 3.FH of SCD at age less than 45 years 
 4.coved-type ECG in family members 
 5.inducibility of VT with PES 
 6.syncope; 7.nocturnal  agonal respiration 
 
 Administration of :Ajmalin,Flecainide,Procainamide 
 
 Test is  terminated when:1. type 1  developes 
 2.ST elevation  in type 2 increases by at least 2 mm 
3.PVC or other  arrythmia develop 
 4.QRS widens by 30% or more  
 
 Isoproterenol  and Sodium lactate  can be effective 
antidotes 
 Negative results of genetic testing does not 
exclude the presence of the disease 
 BS is a channelopathy that causes current 
dysfunction in those channels participating in the 
generation of  the cardiac  action potential. 
 SCN5A is the first gene linked to BS 
 The cellular basis  is though to be the result of  
loss of function of Na+ channels(reduced   INa) 
that differentially alters the action potential 
morphology  in epicardial versus endocardial 
cells. 
 The excessive increase in intramural dispersion of 
repolarization(between epicardium and 
endocardium) facilitates reentrant  exitation 
waves between  depolarized  endocardium and 
prematurely repolarized epicardium. 
 RVOT  is the critical ares  and is a frequent origin 
of VT and VF  
 In addition  to blocking INa   ,has a relatively 
strong effect in blocking Ito .Hence,quinidine 
can effectively suppress ST elevation and 
ventricular arrythmia in patients with the BS. 
 Beta-adrenergic stimulation induces  
increased inward ICaL ,and attenuates  the 
excess of outward current,resulting in 
reduction of ST elevation .(Isoproterenol) 
 Verapamil,lithium,H1 antihistamines,propofol, 
 Alcohol intoxication,cocain intoxication. 
 Vagomimetic  agents,beta blockers 
 Male  gender , Spontaneous occurrence  of  type 
1 >>>>higher risk for cardiac events 
 Asymptomatic   Pts. In whom  ST elevation  
appeared only  after drug test >>>low risk 
 FH of SCD  at age < 45y/o  , coexistence of early 
repolarization  in the inferolateral leads 
>>>>poor outcome 
 
 ICD  
 For asymptomatic patients with normal baseline 
ECG and those with spontaneous type I Brugada 
ECG but  noninducible  VT/VF  during PES 
,reassurance is adequate management. 
 Monomorphic PVCs originated  in the RVOT or 
RV Purkinje network  are often the trigger for VT, 
and focal RF ablation of the PVCs can be valuable 
in reducing the burden of arrhythmias  and ICD 
therapies. 
 Extensive ablation over the RVOT epicardium 
can revert the ECG pattern to normal and 
eliminate episodes of VT/VF. 
 Quinidine :high dose(1200 – 1500 mg/day) 
 Denopamin :an alpha/beta-adrenergic stimulant  
 Cilostazol :a phosphodiesterase III inhibitor  that 
increases  Ical , 
 Bepridil :was shown to suppress the incidence of 
VF episodes,probably by blocking Ito. 
 Isoproterenol   
 Antiarrhythmic (class IA,IC) 
 Betablockers 
 Ttricyclic antidepressants 
 Propofol 
 K+ channel activators(pinacidil) 
 Lithium 
 Cocain  
 Alpha-adrenergic agonist(methoxamin) 
 Vagomimetic agents 


 Inherited  channelopathy  
 Occuring  in young individuals with structurally 
normal heart 
 Short QT(QTc <320 ms) associated with 
AF,syncope,and/or SCD 
 Majority of affected subjects :men 
 Age: variable,from infancy to the 8 decade of 
life,with a mean age of 20-30 y 
 Cardiac arrest  is the first clinical manifestation in 
1/3  of patients. 
 Syncope(14%) 
 AF (30%) 
 
 Cardiac arrest has occurred both at rest and 
under stress 
 Extreme abbreviation of the Jpoint-Tpeak  interval  
 (<120 ms)can help distinguish  patients with 
SQTS from healthy subjects with an apparent 
abbreviation of the ST and shortened 
QT(mean Jpoint-Tpeak  interval of 188 ms. 
 High-amplitude,narrow,symmetrical T waves in the precordial leads  
 QTc 
 <370                                   1 
 <350                                   2 
 <330                                   3 
 Jpoint-Tpeak <120    1 
 H/O SCA                                                                          2 
 Documented polymorphic VT or VF                     2 
 Unexplained syncope                                                  1 
 AF                                                                                         1 
 1th  or 2ed –degree ,high probability SQTS         2 
 1th  or 2ed –degree,autopsy-neg.SCD                    1 
 Sudden infant death syndrom                                    1 
 
 Genotype 
 Positive                                                                                 2 
 Mutation in culprit gene                                                 1 
 Intermediate probability :3 




 Other etiologies for shortening of the QT interval 






 -administration of acetylcholine and catecholamines 
 ICD  
 quinidine 

 Familial  polymorphic VT 
 Rare  
 Highly malignant  
 Inherited arrhythmia disorder 
 Exercise-and stress-induced polymorphic or  
bidirectional VT 
 Structurally normal heart 
 Mean age of onset:7-9y 
 Approximately 30% ,have a F/H of stress-related 
syncope,seizure,SCD before age 40y. 
 There is a high level of penetrance of the disease 
(75% to 80%) 

 Isoproterenol   
 Holter monitoring 
 Invasive EP testing is of no value in the diagnosis 
or risk stratification 
 Genetic testing(cardiac Ryanodine receptor gene 
     RyR2) 
 Sarcoplasmic reticulum load is normal,there is no 
Ca2+leak.Under beta-areneergic(sympathetic) 
stimulation,sarcoplasmic reticulum Ca2+ 
concentration becomes elevated above the 
reduced threshold,causing Ca2+ to leak out of 
the  sarcoplasmic reticulum. 
 Mechanism of the bidirectinal morphology of VT 
is not clear 
 Betablockers:nadolol 1 to 2.5 mg/kg /d  or 
propranolol 2.5-3.5 mg/kg/d 
 IV propranolol for acute management 
 Addition  of flecainide to betablocker(flecainide 
effects are mediated by direct blockade of RyR2 
channels and reduction of Ca2+ spark amplitude 
rather than Na+channel blockade 
 Verapamil (an inhibitor of RyR2) 
 ICD 
 Catheter ablation(monomorphic PVCs) 
left cardiac sympathetic denervation 
 
